The inter-relationship of the triad: osteoporosis, fracture risk, and obesity—a longitudinal multicenter analysis by the Egyptian Academy of Bone Health

Egyptian Rheumatology and Rehabilitation

Table 3 Obesity and fractures: comparison of the fracture risks assessed by FRAX among the study cohort stratified according to their BMI

	Normal weight [N = 75] N (%)	Overweight [N = 87] N (%)	Obese [N = 90] N (%)	p value
History of fragility fracture	25 (33.3)	40 (46.0)	43 (47.8)	0.134 NS
Last year fall	32 (42.7)	48 (55.2)	61 (78.8)	0.01
FRAX^a				0.007
No risk	5 (10.2)	9 (10.3)	17 (18.9)
Intermediate risk	12 (24.5)	19 (21.8)	35 (38.9)
High risk	32 (65.3)	35 (40.2)	26 (28.9)
Sarcopenia (high risk)	31 (40.8)	47 (54.0)	63 (70)	0.05
Functional disability (high risk) by HAQ	31 (40.8)	38 (43.7)	59 (65.6)	0.05
Osteoporosis (T-score ≤ 2.5)	38 (90.5)	42 (48.3)	32 (35.6)	0.001

Bold values indicate statistical significance at p ≤ 0.05
BMI, body mass index; FRAX, fracture risk assessment; HAQ, health assessment questionnaire
^aFRAX: no risk—major osteoporosis fracture risk < 10% and hip fracture risk < 1%; intermediate risk—major osteoporosis fracture risk 10– < 20% and hip fracture risk < 1– < 3%; high risk—major osteoporosis fracture risk ≥ 20% and hip fracture risk ≥ 3%)